IHC-Guaranteed Antibody Preparation Service

Immunohistochemistry is one of the most demanding applications an antibody can be asked to perform. Before an antibody even reaches the tissue, the sample has been fixed, embedded, sectioned, and often subjected to antigen-retrieval treatment — a sequence that alters or masks many epitopes. An antibody that performs well in ELISA or Western blot may therefore fail completely on tissue, staining background instead of the target or missing the antigen altogether. An IHC-guaranteed antibody is one that has been selected and validated to work under exactly these conditions.

The difference lies in screening. Rather than testing candidates only for binding, an IHC-focused project screens them against real tissue sections, so that the antibody delivered has been shown to give the expected staining pattern. That step is what many standard antibody projects skip, and it is the reason a tissue-focused service produces reagents that behave in the application they were made for.

We provide IHC-guaranteed antibody preparation as a defined service: candidates are generated or obtained, screened for IHC performance, validated on relevant tissue, and delivered with the evidence that supports their use. Projects can start from the antigen itself or from an existing panel of clones.

What the Service Covers

• IHC-based screening of candidates – antibodies assessed on tissue sections for correct localization and clean specificity, rather than for binding alone.
• Screening of existing hybridoma or clone panels – identifying which clones in a panel genuinely work in IHC, so that scarce or already-developed candidates are not wasted.
• Validation on relevant tissue – confirming the expected staining pattern against the tissue type the reagent is intended for.
• Delivery of a validated reagent – the selected antibody supplied with the staining results that demonstrate its IHC performance.

Why IHC Is More Demanding Than Other Assays

The same antibody that works in a solution-based assay may not work on tissue, because the antigen is not in the same state.

Workflow

• Define target and tissue – agree the antigen, the tissue type, and the expected staining pattern.
• Produce or obtain candidates – generate antibodies, or take an existing hybridoma or clone panel forward.
• Screen for IHC performance – test candidates on tissue and select those that stain the target correctly.
• Validate on tissue – confirm the staining pattern on the tissue of interest before release.
• Deliver – supply the validated antibody with the supporting staining data.

Applications

• Pathology research reagents – antibodies for tissue-based studies of protein distribution and disease.
• Diagnostic reagent development – IHC reagents intended for diagnostic workflows.
• Clone-panel validation – determining which clones in a panel are usable in tissue work.
• Tissue-level evidence – studies that require protein localization in situ rather than in a lysate.

Why Work With Us

An antibody is only as good as the application it is used in, and for tissue work that means screening must happen on tissue. We keep the intended application central to the project, test candidates under the conditions they will be used in, and report the staining results alongside the reagent so the evidence travels with it. Where a candidate stains background or misses the target, we exclude it rather than pass it on, so the antibody you receive has already cleared the hurdle that matters most.